重新审视良性前列腺增生的定量多参数MRI及其与移行区癌的鉴别
本研究纳入60例确诊前列腺癌并接受术前3T MRI的患者,测量移行区内前列腺癌与囊性、腺体性或间质性良性前列腺增生的T2、ADC及DCE-MRI定量参数。ADC值在前列腺癌显著低于所有类型良性增生(p<0.001),鉴别AUC=0.87;DCE-MRI参数无法区分二者。
要点
- ADC值鉴别移行区前列腺癌与良性增生准确性高(AUC=0.87,p<0.001)。
- T2值仅在前列腺癌与囊性良性增生间有显著差异(p<0.001)。
- DCE-MRI参数在前列腺癌与良性增生间无显著差异,无法鉴别。
核心结论
- 定量多参数MRI尤其是ADC值可用于鉴别前列腺癌与良性前列腺增生,改善移行区前列腺癌诊断;DCE-MRI参数无法有效区分二者。
研究设计与样本
- 60例确诊前列腺癌患者接受术前3T MRI(T2加权、多回波T2加权、扩散加权及动态增强成像),随后行前列腺切除术,将移行区内前列腺癌与囊性、腺体性或间质性良性增生与MRI匹配并测量定量参数。
关键影像表现/征象
- 前列腺癌ADC值显著低于所有类型良性前列腺增生(p<0.001)。
- 前列腺癌T2值显著低于囊性良性增生(p<0.001),与腺体性(p=0.27)及间质性良性增生(p=0.99)无显著差异。
- DCE-MRI上良性前列腺增生在移行区模拟前列腺癌,二者无显著差异。
- 腺体性良性增生ADC=1.31±0.22 µm2/ms、T2=115.7±37.3 ms,囊性良性增生ADC=1.92±0.43 µm2/ms、T2=242.8±117.9 ms,二者显著不同。
- 腺体性与间质性良性增生间ADC(p=0.72)和T2(p=0.46)无显著差异。
诊断标准与关键数值
- ADC值鉴别前列腺癌与良性前列腺增生的AUC=0.87(p<0.001)。
临床应用与阅片要点
- 定量ADC值有助于鉴别移行区前列腺癌与良性前列腺增生。
- DCE-MRI参数不能有效区分前列腺癌与良性前列腺增生。
- 腺体性良性增生在ADC和T2上并非既往认为的高信号,其定量mpMRI测量值与间质性良性增生相似。
- 腺体性与囊性良性增生在mpMRI上表现不同,组织学亦不同。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study investigates the multiparametric MRI (mpMRI) appearance of different types of benign prostatic hyperplasia (BPH) and whether quantitative mpMRI is effective in differentiating between prostate cancer (PCa) and BPH.
MATERIALS AND METHODS: Patients (n = 60) with confirmed PCa underwent preoperative 3T MRI. T2-weighted, multi-echo T2-weighted, diffusion weighted and dynamic contrast enhanced images (DCE) were obtained prior to undergoing prostatectomy. PCa and BPH (cystic, glandular or stromal) were identified in the transition zone and matched with MRI. Quantitative mpMRI metrics: T2, ADC and DCE-MRI parameters using an empirical mathematical model were measured.
RESULTS: ADC values were significantly lower (p < 0.001) in PCa compared to all BPH types and can differentiate between PCa and BPH with high accuracy (AUC = 0.87, p < 0.001). T2 values were significantly lower (p < 0.001) in PCa compared to cystic BPH only, while glandular (p = 0.27) and stromal BPH (p = 0.99) showed no significant difference from PCa. BPH mimics PCa in the transition zone on DCE-MRI evidenced by no significant difference between them. mpMRI values of glandular (ADC = 1.31 ± 0.22 µm2/ms, T2 = 115.7 ± 37.3 ms) and cystic BPH (ADC = 1.92 ± 0.43 µm2/ms, T2 = 242.8 ± 117.9 ms) are significantly different. There was no significant difference in ADC (p = 0.72) and T2 (p = 0.46) between glandular and stromal BPH.
CONCLUSIONS: Multiparametric MRI and specifically quantitative ADC values can be used for differentiating PCa and BPH, improving PCa diagnosis in the transition zone. However, DCE-MRI metrics are not effective in distinguishing PCa and BPH. Glandular BPH are not hyperintense on ADC and T2 as previously thought and have similar quantitative mpMRI measurements to stromal BPH. Glandular and cystic BPH appear differently on mpMRI and are histologically different.
引用
- Chatterjee A, Gallan AJ, He D, et al. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer. Abdom Radiol (NY). 2019. PMID: 30955071. doi:10.1007/s00261-019-01936-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。